中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 6
Jun.  2016

Research advances in computed tomography and magnetic resonance imaging findings of cirrhotic portal hypertension

DOI: 10.3969/j.issn.1001-5256.2016.06.011
  • Published Date: 2016-06-20
  • Portal hypertension is the most common complication of liver cirrhosis.Noninvasive radiological examinations have important values in evaluating liver parenchyma,collateral circulation,and esophagogastric variceal bleeding in liver cirrhosis.Computed tomography(CT) and magnetic resonance imaging(MRI) can reflect the changes in liver morphology,the density and signals of liver parenchyma,and hemodynamics and have important values in disease diagnosis and prognostic evaluation.CT and functional MRI,such as perfusion- weighted imaging,MR elastography,and MR diffusion- weighted imaging,can provide quantitative information and can be applied in the diagnosis of hepatic fibrosis and early- stage liver cirrhosis in clinical practice.CT angiography and MR angiography,especially unenhanced MR angiography,can show the condition of the branches of portal vein,which helps to evaluate the risk of esophagogastric variceal bleeding and detect the markers for early warning.A combination of CT and MRI and evaluation of their potential in clinical application can give full play to the role of radiological examinations in the diagnosis,evaluation,and prognostic analysis of cirrhotic portal hypertension.

     

  • [1] BARR DC,HUSSAIN HK.MR imaging in cirrhosis and hepatocellular carcinoma[J].Magn Reson Imaging Clin N Am,2014,22(3):315-335.
    [2] FARIA SC,GANESAN K,MWANGI I,et al.MR imaging of liver fibrosis:current state of the art[J].Radiographics,2009,29(6):1615-1635.
    [3]LONG LL,HUANG ZK,DING K,et al.The value of multi-slice spiral CT liver perfusion imaging to evaluate the chronic hepatic fibrosis and cirrhosis[J].Chin J Radiol,2012,46(4):317-321.(in Chinese)龙莉玲,黄仲奎,丁可,等.多层螺旋CT肝脏灌注成像评价慢性肝纤维化、肝硬化的价值[J].中华放射学杂志,2012,46(4):317-321.
    [4] HAGIWARA M,RUSINEK H,LEE VS,et al.Advanced liver fibrosis:diagnosis with 3D whole---liver perfusion MR imaging-initial experience[J].Radiology,2008,246(3):926-934.
    [5]KIM D,KIM WR,TALWALKAR JA,et al.Advanced fibrosis in nonalcoholic fatty liver disease-noninvasive assessment with MRelastography[J].Radiology,2013,268(2):411-419.
    [6] LOOMBA R,WOLFSON T,ANG B,et al.Magnetic Resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease a prospective study[J].Hepatology,2014,60(6):1920-1928.
    [7] YOON JH,LEE JM,JOO I,et al.Hepatic fibrosis:prospective comparison of MR elastography and us shear-wave elastography for evaluation[J].Radiology,2014,273(3):772-782.
    [8] HANNA RF,AGUIRRE DA,KASED N,et al.Cirrhosis-associated hepatocellular nodules-correlation of histopathologic and MRimaging features[J].Radiographics,2008,28(3):747-769.
    [9] HUSSAIN SM,REINHOLD C,MITCHELL DG.Cirrhosis and lesion characterization at MR imaging[J].Radiographics,2009,29(6):1637-1652.
    [10]YAN FH,ZHOU KR,SHEN JZ,et al.Comparason of enhancement patterns of multi-phase scan of dynamic MRI and dynamic CT in small hepatocellular carcinoma[J].Chin J Oncol,2001,23(5):413-416.(in Chinese)严福华,周康荣,沈继章,等.MR和CT动态扫描对小肝癌强化特征的比较研究[J].中华肿瘤杂志,2001,23(5):413-416.
    [11]YAN FH,ZHOU KR,WU D,et al.Evaluation of dynamic enhanced fast multiplanar spoiling gradient recalled(FMPSPGR)in the diagnosis of small hepatocellular carcinoma[J].Chin J Hepatol,2001,9(3):139-141.(in Chinese)严福华,周康荣,吴东,等.快速多层面干扰梯度回波序列动态增强扫描在小肝癌诊断中的价值评估[J].中华肝脏病杂志,2001,9(3):139-141.
    [12]XU PJ,YAN FH,WANG JH,et al.The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion(≤3cm)detection[J].Natl Med J China,2009,89(9):592-596.(in Chinese)徐鹏举,严福华,王建华,等.弥散加权成像对肝细胞癌小病灶检测的价值[J].中华医学杂志,2009,89(9):592-596.
    [13]XU PJ,YAN FH,WANG JH,et al.The comparative study of diffusion-weighted MR imaging with modified sensitivity encoding technique for small hepatocellular carcinoma lesions[J].Chin J Radiol,2007,41(1):5-9.(in Chinese)徐鹏举,严福华,王建华,等.改良敏感编码技术在肝脏MR扩散加权成像中对肝细胞癌小病灶的影响[J].中华放射学杂志,2007,41(1):5-9.
    [14] PARK MJ,KIM YK,LEE MW,et al.Small hepatocellular carcinomas:improved sensitivity by combining ga-doxetic acid-enhanced and diffusion-weighted MR imaging patterns[J].Radiology,2012,264(3):761-770.
    [15] LIU X,ZOU L,LIU F,et al.Gadoxetic acid disodium-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma:a meta-analysis[J].PLo S One,2013,8(8):e70896.
    [16] CHOI JY,LEE JM,SIRLIN CB.CT and MR imaging diagnosis and staging of hepatocellular carcinoma:part II.Extracellular agents,hepatobiliary agents,and ancillary imaging features[J].Radiology,2014,273(1):30-50.
    [17]LEE JY,KIM TY,JEONG WK,et al.Clinically severe portal hypertension:role of multi-detector row CT features in diagnosis[J].Dig Dis Sci,2014,59(9):2333-2343.
    [18] KANG HK,JEONG YY,CHOI JH,et al.Three-dimensional multi-detector row CT portal venography in the evaluation of portosystemic collateral vessels in liver cirrhosis[J].Radiographics,2002,22(5):1053-1061.
    [19]ZHU H,SHI B,UPADHYAYA M,et al.Therapeutic endoscopy of localized gastric varices:pretherapy screening and posttreatment evaluation with MDCT portography[J].Abdom Imaging,2010,35(1):15-22.
    [20]WANG F,SHEN JL,HUA J,et al.A study of applications of spectral CT in predicting the risk of variceal bleeding of liver cirrhosis with portal hypertension[J].Radiol Pract,2015,30(7):763-767.(in Chinese)王芳,沈加林,华静,等.能谱CT在预测肝硬化门脉高压食管静脉曲张出血风险的应用[J].放射学实践,2015,30(7):763-767.
    [21] ANNET L,MATERNE R,DANSE E,et al.Hepatic flow parameters measured with MR imaging and Doppler US:correlations with degree of cirrhosis and portal hypertension[J].Radiology,2003,229(2):409-414.
    [22] ANNET L,PEETERS F,HORSMANS Y,et al.Esophageal varices:evaluation with transesophageal MR imaging--initial experience[J].Radiology,2006,238(1):167-175.
    [23] SHIN SU,LEE JM,YU MH,et al.Prediction of esophageal varices in patients with cirrhosis:usefulness of three-dimensional MRelastography with echo-planar imaging technique[J].Radiology,2014,272(1):143-153.
    [24] GOUYA H,VIGNAUX O,SOGNI P,et al.Chronic liver disease:systemic and splanchnic venous flow mapping with optimized cine phase-contrast MR imaging validated in a phantom model and prospectively evaluated in patients[J].Radiology,2011,261(1):144-155.
    [25] GOUYA H,GRABAR S,VIGNAUX O,et al.Portal hypertension in patients with cirrhosis:indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging[J].Eur Radiol,2015.[Epub ahead of print]
  • Relative Articles

    [1]Chen YANG, Shanghai YU, Feipeng XU, Hua ZHANG. Application of magnetic resonance imaging-proton density fat fraction in liver fat quantification[J]. Journal of Clinical Hepatology, 2024, 40(3): 600-605. doi: 10.12449/JCH240327
    [2]Lu HUANG, Lijian LU. Value of MRI biliary score and liver/muscle ratio in evaluating the pathological grade of liver fibrosis[J]. Journal of Clinical Hepatology, 2024, 40(4): 720-725. doi: 10.12449/JCH240413
    [3]Mu Rong, Lu LunGen. Advances in the application of magnetic resonance imaging in hepatic fat quantification in patients with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(6): 1366-1369. doi: 10.3969/j.issn.1001-5256.2020.06.038
    [4]Wang LiLi, Li JunFeng, Dou Yu, Guo ShunLin, Lei JunQiang. Value of magnetic resonance functional imaging in evaluating microvascular invasion of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(12): 2681-2684. doi: 10.3969/j.issn.1001-5256.2018.12.038
    [5]Chen QiPing, Lin Su, Shi ZhenShan, Zhu YueYong, Li YouBing. A cost-effectiveness analysis of Gd-EOB-DTPA contrast-enhanced magnetic resonance imaging versus ultrasound in hepatocellular carcinoma screening[J]. Journal of Clinical Hepatology, 2018, 34(9): 1917-1920. doi: 10.3969/j.issn.1001-5256.2018.09.018
    [6]Pan Qi, Luo ChunHai, Ma WanLing, Qu YuanFei, Wang JianRu, Chen Lin. Specific magnetic resonance imaging of vascular endothelial growth factor-C targeted molecular probe and its clinical significance in a rat model of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(7): 1492-1496. doi: 10.3969/j.issn.1001-5256.2018.07.025
    [7]Li JingBo, Liu Shu, Wen Bo, Gao Nan, Wang BingYuan. Clinical significance of Fibro Touch,ultrasound,and computed tomography in diagnosis of fatty liver disease: a comparative analysis[J]. Journal of Clinical Hepatology, 2016, 32(3): 459-462. doi: 10.3969/j.issn.1001-5256.2016.03.011
    [8]Wu Jie, Jing ZongLin. Research advances in MRI features and diagnosis of hepatocellular adenomas[J]. Journal of Clinical Hepatology, 2016, 32(10): 2012-2015. doi: 10.3969/j.issn.1001-5256.2016.10.045
    [9]Zhai YaNan, Li Lei, Yin Liang, Guo QiHong, Lei JunQiang, Guo ShunLin, Zhang ChunYu, Wang HaiJun, Wen XiaoXiao. Role of dual-source CT low-dose whole liver perfusion imaging in evaluating liver blood perfusion after transjugular intrahepatic portosystemic shunt in cirrhotic patients with portal hypertension[J]. Journal of Clinical Hepatology, 2016, 32(10): 1894-1899. doi: 10.3969/j.issn.1001-5256.2016.10.014
    [10]Luo YongHeng, Xiao EnHua. Role of functional magnetic resonance imaging in evaluating the therapeutic effect of transcatheter arterial chemoembolization in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2016, 32(12): 2277-2281. doi: 10.3969/j.issn.1001-5256.2016.12.010
    [11]Wang LiLi, Lei JunQiang, Guo JiGang, Yin Liang, Zhai YaNan, Li JinKui, Chen Hong, Guo ShunLin. Value of Gd-EOB-DTPA-enhanced MRI in assessing liver function[J]. Journal of Clinical Hepatology, 2015, 31(5): 749-753. doi: 10.3969/j.issn.1001-5256.2015.05.028
    [12]Zeng MengSu, Li RuoKun. Clinical value of susceptibility-weighted imaging for studying the multi-step hepatocarcinogenic process of cirrhotic liver nodules[J]. Journal of Clinical Hepatology, 2013, 29(1): 38-41.
    [13]Gu Han, Li Cheng. Research progress in magnetic nanoparticles for magnetic resonance imaging and targeted therapy of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2013, 29(10): 740-743. doi: 10.3969/j.issn.1001-5256.2013.10.005
    [14]Huang RuiSui, Li Cheng, Gu Han, Jiao ZhiYun. Establishment of rat model of liver cirrhosis or liver cancer and its magnetic resonance images before and after superparamagnetic iron oxide enhancement[J]. Journal of Clinical Hepatology, 2013, 29(10): 769-774. doi: 10.3969/j.issn.1001-5256.2013.10.012
    [15]Mai Jing, Gao YueQiu. The application of magnetic resonace elastography in the non-invasive diagnosis of hepatic fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(3): 318-320+324.
    [18]Zhao GuoKu, Chen Kai, Zhou HongWei. MRI diagnostic value of liver adenoma[J]. Journal of Clinical Hepatology, 2004, 20(5): 291-292+321.
    [19]Ding Sheng, Wang Li, Yan XinMin, Zhou JianYong. Comparison of the diagnosis between CT and B mode ultrasoud in faffy liver.[J]. Journal of Clinical Hepatology, 2002, 18(6): 372-373.
    [20]Wu JianBing, Ni YongWen, Huang Ping, Li Xiao, Wang QingShan. CT-guided percutaneous intratumoral injection of lipiodol adriamycin ethanol for the treatment of liver cancer[J]. Journal of Clinical Hepatology, 2001, 17(1): 51-52.
  • Cited by

    Periodical cited type(19)

    1. 贾俊芳,黄俊,段廷贺. MSCT与MRI对肝小静脉闭塞病的诊断价值. 黑龙江医药科学. 2021(01): 166-167 .
    2. 董健,何福亮,王磊,岳振东,刘福全,温廷国,陈孝柏,王仁贵. 能谱CT去金属伪影技术在胃冠状静脉栓塞术后门静脉成像中的应用价值研究. 临床放射学杂志. 2020(01): 188-192 .
    3. 梁炎辉,吴金棉,黄洲,刘怀忠,梁绍锋,刘银辉. 多层螺旋CT门静脉造影诊断肝硬化门静脉高压的作用及影像学特点. 现代医用影像学. 2020(08): 1455-1458 .
    4. 周宝鹤. 多层螺旋CT门静脉成像在肝硬化中医证型诊断中的应用研究. 新中医. 2020(22): 56-58 .
    5. 荆航,李兰涛,王振光. MRI与CT多期动态增强扫描在肝硬化合并原发性肝癌中的诊断价值比较. 医疗卫生装备. 2019(03): 61-63+84 .
    6. 李安源,高兵红,张金玲,唐亮,刘秀娟,纪凤颖,马志文,李东. CT灌注成像在兔早期肝硬化诊断中的应用价值研究. 现代生物医学进展. 2019(04): 626-630 .
    7. 陈少铭. 肝硬化结节CT与核磁共振成像的价值观察. 现代医用影像学. 2019(05): 1051-1052 .
    8. 王艳丽,阿娜尔·阿肉甫汗. 肝硬化及门脉高压早期核磁共振诊断结果分析. 影像研究与医学应用. 2019(13): 151-152 .
    9. 吕美光,潘新智. 肝硬化门静脉高压食管胃静脉曲张出血的预防治疗研究. 中国医药科学. 2019(11): 226-229 .
    10. 高德军,罗鹰,陈首名,何志兵. 双源CT门静脉成像在肝硬化门静脉侧支循环的临床应用. 中国CT和MRI杂志. 2019(08): 100-102+106 .
    11. 马关华,陈小宇,梁宇豪,梁洪生. 肝硬化应用腹部CT的诊断价值分析. 中国现代药物应用. 2019(15): 39-41 .
    12. 罗艺,秦俭,修志刚,王玉,董官伟,郑仕诚,李军,谢春艳. 肝硬化食管静脉曲张出血风险的MSCTA评估研究. 成都医学院学报. 2019(06): 758-763+768 .
    13. 唐钰,段春凤. 肝硬化结节CT与核磁共振成像的临床观察. 中国医药指南. 2018(15): 142-143 .
    14. 李双庆. 超声检查在肝硬化门静脉高压诊断中的临床应用. 世界最新医学信息文摘. 2018(96): 152+154 .
    15. 龚红霞,邱晶. 多层螺旋CT门静脉成像在肝硬化中医证型诊断中的应用价值. 西部中医药. 2018(12): 147-149 .
    16. 李伯龙,彭心宇,乔飞,徐强,赵伯文. 能谱CT在肝胆疾病诊断中的应用. 临床肝胆病杂志. 2017(03): 593-598 . 本站查看
    17. 王梅,王健. CT多期动态增强扫描在诊断肝硬化合并原发性肝癌中的应用价值. 当代医药论丛. 2017(22): 8-9 .
    18. 李彦蓉. 肝硬化门静脉高压CT和磁共振成像的表现及研究进展. 现代医药卫生. 2017(14): 2138-2140 .
    19. 林栋. CT、MR功能成像在肝脏病变的应用进展探究. 影像研究与医学应用. 2017(17): 35-37 .

    Other cited types(7)

  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2942) PDF downloads(526) Cited by(26)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return